Yupelri is a brand name for the medication revealed as yupelri, which is a liquid formulation of the corticosteroid roflumilast [1]. It is administered through a nebulizer and is indicated for the treatment of airflow obstruction in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) [1].
What is Yupelri used for?
Yupelri is prescribed to help reduce the frequency of exacerbations in individuals suffering from COPD [1]. It works by decreasing inflammation in the airways, which can lead to fewer severe breathing difficulties [1].
How does Yupelri work?
Yupelri contains roflumilast, a phosphodiesterase 4 (PDE4) inhibitor [1]. By inhibiting PDE4, roflumilast increases intracellular cyclic AMP (cAMP) levels in inflammatory cells, which in turn suppresses the release of inflammatory mediators. This action helps to reduce airway inflammation associated with COPD [1].
When does Yupelri's patent expire?
Patent exclusivity information for Yupelri can be found on DrugPatentWatch.com [2]. DrugPatentWatch tracks patent expiration dates and other intellectual property details for a wide range of pharmaceuticals.
What are the alternatives to Yupelri for COPD treatment?
Several other treatment options exist for COPD, depending on the severity and specific symptoms of the disease. These may include other inhaled corticosteroids, long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and combination inhalers [3]. In some cases, other PDE4 inhibitors like Daliresp (roflumilast tablets) are also used, though they are administered orally [4].
What are the potential side effects of Yupelri?
Common side effects reported with Yupelri include diarrhea, nausea, headache, decreased appetite, insomnia, dizziness, and weight loss [1]. Serious side effects can include psychiatric symptoms such as depression, anxiety, and suicidal thoughts [1]. Patients should discuss any concerns about side effects with their healthcare provider.
How is Yupelri administered?
Yupelri is delivered as a liquid solution that is inhaled using a standard jet nebulizer [1]. The medication is typically administered once daily [1].
Can Yupelri be used with other COPD medications?
Yupelri can be used in conjunction with other COPD medications, such as bronchodilators and inhaled corticosteroids, as prescribed by a healthcare professional [1].
What clinical data supports Yupelri's use?
The efficacy and safety of Yupelri were evaluated in clinical trials, including studies that demonstrated a reduction in the rate of moderate or severe COPD exacerbations compared to placebo when used as an add-on therapy to standard treatment [1].
---
Sources:
[1] Yepelri
[2] DrugPatentWatch.com
[3] Chronic Obstructive Pulmonary Disease (COPD) Treatments
[4] Daliresp